Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with down syndrome.
about
Potential Role of JAK-STAT Signaling Pathway in the Neurogenic-to-Gliogenic Shift in Down Syndrome BrainTiming of therapies for Down syndrome: the sooner, the betterBuilding an adaptive brain across development: targets for neurorehabilitation must begin in infancyMouse models of Down syndrome as a tool to unravel the causes of mental disabilitiesNeurological phenotypes for Down syndrome across the life spanPharmacotherapy with fluoxetine restores functional connectivity from the dentate gyrus to field CA3 in the Ts65Dn mouse model of down syndromeSex differences in protein expression in the mouse brain and their perturbations in a model of Down syndrome.Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndromeTranslating dosage compensation to trisomy 21Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome.Allocentric spatial learning and memory deficits in Down syndromeA Sonic hedgehog (Shh) response deficit in trisomic cells may be a common denominator for multiple features of Down syndromeTrisomy 21 and early brain developmentMolecular and cellular alterations in Down syndrome: toward the identification of targets for therapeuticsAbsence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.Connecting Synaptic Activity with Plasticity-Related Gene Expression: From Molecular Mechanisms to Neurological Disorders.Weaker control of the electrical properties of cerebellar granule cells by tonically active GABAA receptors in the Ts65Dn mouse model of Down's syndrome.The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for Down syndromeModelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.Is it possible to improve neurodevelopmental abnormalities in Down syndrome?Stem and progenitor cell dysfunction in human trisomies.SNX27, a protein involved in down syndrome, regulates GPR17 trafficking and oligodendrocyte differentiation.Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome.Apoptosis in Down's syndrome: lessons from studies of human and mouse models.Early pharmacotherapy with fluoxetine rescues dendritic pathology in the Ts65Dn mouse model of down syndrome.Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology.The distribution and frequency of pulmonary neuroendocrine cells in Down syndrome fetal lungs.Defects in nerve conduction velocity and different muscle fibre-type specificity contribute to muscle weakness in Ts1Cje Down syndrome mouse model.The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.Integrated Quantitative Transcriptome Maps of Human Trisomy 21 Tissues and Cells.
P2860
Q26765647-6AC45B08-52AC-42E1-AC0A-9808796E4B0AQ26779297-8082FED5-5599-41B5-AB4A-52BE4D36D748Q26781609-080F1454-F999-4C47-8FDE-44A30138FA4AQ26863005-83B05493-8648-4AA3-9372-E5684A7A2589Q27025698-AD0D97F6-BD14-4C70-B56B-F45CEB814FF6Q28486301-E4400644-B1C1-4BFE-A597-2FF00A0EEE85Q30398962-ACEC09F8-F519-40E7-8AD7-94752631CEE2Q33643589-232A1CB4-3D87-4644-931D-D69736147600Q34037496-FB3BF35A-4D30-4832-A985-406405129C02Q34229190-4A367879-3547-4009-9C6B-3C5A71753AA1Q34339997-D1F96D63-6C55-4D6F-8618-B38F4046FC6CQ35087311-AB9269D7-B871-4E2B-B7AF-0F6AABD924D5Q35509854-EC2A6D28-7220-4AF9-B28A-4E5A3334B2AAQ35740129-1F3D099C-8FB9-443C-838A-BD414D4E6DACQ36111546-0D01B099-5455-4BB4-A9DB-46EB39DF56B6Q36665885-F5BA5975-0B58-4B1F-B270-31404E809D14Q36759628-010C991B-2852-4A5E-9849-33CD2B5CF4DFQ37045414-BE59BD5D-5732-4A85-9C88-7F21EE3CA502Q37175063-27DE3FFF-0251-4F86-B849-A9AD1AEB459CQ37591118-0A5BEF9D-426A-458E-8A4D-5949B6CEE7A0Q37912174-C649C1C5-5D26-4ED6-BA37-4DF071799F58Q38292512-C3C771BC-25D9-4806-B69A-9E817B0612EBQ39704371-5CC588D4-8E83-40D7-8ED2-AA0C5A3FF6BDQ42486904-A3E52F98-67BB-439B-BE1D-C2585CD6739FQ43723779-BAC3E19C-1231-40F4-9040-BFB3C35D7F5EQ48433734-E1E695EB-172C-442E-929D-071FDEF83274Q50732745-89AAF715-D30C-4BE4-90FB-B307CDE8F1E5Q51725607-9AFD9777-B7AB-4FD2-BA45-15154BAC7185Q54968002-8067AF7F-1436-4931-926C-096DD090B52DQ54988096-5D6B9DF8-A0D0-4A80-B405-A00030A8D1E5Q55280442-78022645-C044-47A1-B84E-1E54B6754EED
P2860
Widespread proliferation impairment and hypocellularity in the cerebellum of fetuses with down syndrome.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Widespread proliferation impai ...... of fetuses with down syndrome.
@en
Widespread proliferation impai ...... of fetuses with down syndrome.
@nl
type
label
Widespread proliferation impai ...... of fetuses with down syndrome.
@en
Widespread proliferation impai ...... of fetuses with down syndrome.
@nl
prefLabel
Widespread proliferation impai ...... of fetuses with down syndrome.
@en
Widespread proliferation impai ...... of fetuses with down syndrome.
@nl
P2093
P2860
P1433
P1476
Widespread proliferation impai ...... of fetuses with down syndrome.
@en
P2093
Donatella Santini
Paola Bonasoni
Renata Bartesaghi
P2860
P304
P356
10.1111/J.1750-3639.2010.00459.X
P577
2010-12-06T00:00:00Z